April 18–19, 2018Boston Convention & Exhibition CenterBoston, MA

BIOMEDevice Boston 2018 Schedule Viewer

View, browse, and sort the education offerings, networking opportunities, and event activities by using the filters below; you can search by Pass Type, Free Content & Activities, and Conference Track. With this session scheduler, you can build your daily agenda in advance and access the full list of options during the event. Sessions do fill up and seating is first come/first serve, so please arrive early to sessions that you would like to attend.

Kevin NelsonCSOTissueGen

Dr. Nelson, TissueGen's Founder and Chief Scientific Officer, received his Ph.D. from The University of Texas Southwestern Medical Center at Dallas under the direction of Dr. Robert Eberhart. As a faculty member in Biomedical Engineering at the University of Texas at Arlington in 1996, he joined a team working on an NIH grant to develop a fiber-based, bioresorbable vascular stent with the goal of delivering gene therapy to the vessel wall. Simultaneously working with Dr. Nathan Schwade to develop drug-loaded microspheres for improved wound healing, he eventually combined the drug-loading techniques of microspheres with the fiber for the bioresorbable stent, and fiber-based drug delivery was born. Now patented, this technology has been the focus of Dr. Nelson's professional life and the driver behind TissueGen.